CDER NAMES THESE TEN (21 CFR 211) Comment The following represent those most frequent Observations that CDER posted for fiscal year 2010 based on a total of 646 FDA Form 483. REFERENCE             … [Read more...]
FDA Regulatory Compliance for the Pharmaceutical, Biotechnology and Medical Device Arenas